Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-08-06 00:00:00 ET · period of report 2025-07-15 · accession 0001415889-25-021177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-06 | 2025-07-15 | KNSA | Megna Michael R | CAO | A - Grant | $15.63 | +495 | 33.0K | +2% | +$7,737 |
| D | 2025-08-06 | 2025-08-04 | KNSA | Megna Michael R | CAO | M - OptEx | $15.52 | +17.0K | 50.0K | +51% | +$263.8K |
| D | 2025-08-06 | 2025-08-04 | KNSA | Megna Michael R | CAO | S - Sale+OE | $32.35 | -17.0K | 33.0K | -34% | -$550.0K |
| D | 2025-08-06 | 2025-08-04 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -17.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-07-15 | A | A | 495 | $15.63 | 33,041 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-08-04 | M | A | 17,000 | $15.52 | 50,041 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-08-04 | S | D | 17,000 | $32.35 | 33,041 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.01 and $32.895. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Derivative | Share Option | 2025-08-04 | M | D | 17,000 | $0.00 | 0 | D | $15.52 · — to 2030-03-12 | 17,000 Class A Ordinary Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 13, 2020. |